Company intelligence / Profile preview
Rohto Pharmaceutical Co., Ltd.
- Ownership
- Private
- Employees
- ~7259
- Development stage
- Other
Overview
Rohto Pharmaceutical commands a leading share of Japan’s OTC eye drop market (~40%) and has expanded globally with strong positions in Asia-Pacific. The company markets numerous commercial products across eye care, skin care, internal medicine, cosmetics, and functional foods. It has ongoing R&D efforts including clinical trials of novel therapies such as allogeneic stem cell drugs for liver cirrhosis[1][3][7].
- Therapeutic areas
- OtherOphthalmologyGastroenterologyDermatology
- Modalities
- Primarily small molecules and over-the-counter formulationsalso involved in cell therapy research (e.g., allogeneic adipocyte tissue-derived stem cell drug products)
- Industry
- Biotech
Drug pipeline
15 assets14 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Rohto Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rohto Pharmaceutical Co., Ltd..